Pfizer Is Worth $25 Despite Lawsuits And Lipitor Patent Expiry

While an unfavorable outcome will hurt the company?s cash reserves, we believe the patent losses and increased threat from generic competition are the two biggest factors impacting future performance.

Source: http://www.forbes.com/sites/greatspeculations/2012/07/11/pfizer-is-worth-25-despite-lawsuits-and-lipitor-patent-expiry/

consolidate my debt consolidation debt loan payday consumer debt advocate consumer debt collection